v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities    
Net (loss) income $ (12,341,208) $ 2,124,976
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Amortization of debt discount and debt issuance cost 1,633,776 56,796
Depreciation and amortization 133,334 133,334
Stock based compensation 136,247
Stock issued for modification of notes payable 847,062
Stock issued for services 127,200
Foreign currency transaction (gain) loss 5,531 54,321
Remeasurement gain on translation of foreign subsidiary 14,833 (18,954)
Non cash implied interest 4,799
Bad debts 2,256,846
Bad debt, related party 4,403,804
Gain on settlement of debt (2,154,522)
Write-off of inventory 894,341 125,364
Stock issued for loan financing 97,920
Income from employee retention credits (252,405)
Income from insurance on stolen goods (258,129)
Changes in operating assets and liabilities:    
Accounts receivable 1,514,935 (3,214,943)
Other receivables 345,388 (1,489,103)
Loan receivable, related party 84,937
Inventory (2,915,298) 1,884,324
Prepaid expenses 1,306,351 (1,250,023)
Prepaid expense, related party 202,163 (145,092)
Income taxes payable (84,271) 57,312
Contract liabilities (22,726) 10,050
Accounts payable and accrued liabilities 622,099 (2,870,633)
Accounts payable, related party 489,093 61,759
Net cash used in operating activities (2,585,022) (4,803,390)
Cash Flows from Investing Activities
Cash Flows from Financing Activities    
Proceeds from issuance of common stock at IPO 8,397,044
Proceeds from issuing common stock 3,719,547
Advances from related party 235,000 3,528,003
Repayments of advances to related party (135,000) (3,200,000)
Repayment of notes payable, shareholder (10,000,000) (84,500)
Proceeds from notes payable 20,996,250 1,360,000
Payment of loan financing fees (2,024,287)
Repayment of notes payable (8,136,846) (5,196,461)
Net cash provided by financing activities 4,654,664 4,804,086
Effect of exchange rate on cash, cash equivalents and restricted cash (135,249) 54,690
Net increase in cash, cash equivalents and restricted cash 1,934,393 55,386
Cash, Cash Equivalents and restricted cash, beginning of year 787,920 732,534
Cash, Cash Equivalents and restricted cash, end of year 2,722,313 787,920
Cash paid during the period for:    
Interest 2,953,878 3,906,001
Income taxes 147,377
Supplemental Disclosure of Non-cash Investing and Financing Activities:    
Accounts payable converted to loan payable upon settlement 3,770,824
Reduction of short term related party note payable by reduction of prepaid balance 328,003
Issuance of common stock for loan financing 220,869
Issuance of pre-funded warrants for settlement of shareholder notes payable 899,993
Exercise of pre-funded warrants 4
Loan fees payable to lender $ 375,000